ID 08/26 Consultation Paper on Proposed Framework for Protected Cell Companies in Singapore
Executive Summary
MAS has launched Consultation Paper P013-2026 on a **Proposed Framework for Protected Cell Companies (PCCs)** in Singapore, with a consultation window from 07 July 2026 to 07 August 2026. The proposals would introduce a new corporatestructure for MAS-licensed insurance-related entities (including captives, ILS vehicles and sovereign risk pools) that enables statutory segregation of assets and liabilities by cell, materially affecting structuring, risk‑transfer and prudential oversight for insurance groups.
What Changed
- - MAS proposes introducing a Protected Cell Company (PCC) as a new corporate structure comprising a single legal entity with assets and liabilities statutorily segregated into distinct cells within that entity.
- The PCC structure is intended to be available only to MAS-licensed entities engaged in captive insurance, insurance‑linked securities (ILS) and sovereign risk pooling activities, not generally to all insurers.
- Each PCC will have a core and multiple cells, with ring‑fencing of assets and liabilities such that creditors of one cell should not have recourse to assets of other cells or the core, subject to statutory rules.
- The framework is positioned to enable multiple risk issuances and programs within one vehicle, improving cost and operational efficiency compared with establishing multiple standalone insurers or special purpose vehicles.
- MAS signals that the PCC framework will complement existing special purpose reinsurance and alternative risk‑transfer structures, and is conceptually aligned with Singapore’s broader approach to specialised corporate structures (e.g. variable capital
- The consultation focuses on policy proposals; detailed implementing rules (e.g. in the Insurance Act, subsidiary legislation, or Notices/Guidelines) will follow after MAS considers industry feedback.
Suggested Considerations
- Review the MAS Consultation Paper P013-2026 in detail and map proposed PCC requirements against your current and planned captive, reinsurance, ILS and sovereign risk pool structures.
- Conduct an internal impact assessment on how PCC introduction would affect corporate structuring, capital allocation, risk management, and policyholder/investor protections within your group.
- Identify potential use cases for PCCs (e.g. multi‑cell captives, collateralised reinsurance platforms, ILS issuance vehicles, sovereign risk pools) and assess legal, tax, accounting and regulatory implications for each use case.
- Engage legal, compliance, actuarial and treasury functions to develop a coordinated response to MAS addressing prudential treatment, segregation mechanics, governance expectations and disclosure considerations for PCCs.
- Prepare and submit detailed consultation feedback to MAS by 07 August 2026, including any requested clarifications, suggested safeguards, or recommended scope limitations or expansions for PCC usage.
- For groups with existing alternative risk‑transfer structures (e.g. special purpose reinsurance vehicles or offshore PCCs), compare the proposed Singapore PCC framework to current structures and evaluate potential migration, consolidation or parallel‑use strategies.
Key Dates
Compliance Impact
Non‑engagement with the consultation could result in a PCC framework that does not adequately reflect your business model, potentially creating future compliance burden or limiting structuring options. Once final rules are issued, failure to align PCC usage with MAS requirements could lead to supervisory intervention, restrictions on business lines, or enforcement action for governance, prudential
Who is Affected
References
AI-generated analysis. May contain errors or omissions — verify with the original MAS source before acting. Full disclaimer.
Summary
Inform insurers on the issuance of Consultation Paper on Proposed Framework for Protected Cell Companies in Singapore.